ChemicalBook >> CAS DataBase List >>9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID

9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID

CAS No.
71902-47-1
Chemical Name:
9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID
Synonyms
PGD3;PROSTAGLANDIN D3;Prostaglandin D3;ANOICLBSJIMQTA-WXGBOJPQSA-N;Prostaglandin D3 Exclusive;9α,15S-dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oic acid;9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID;(5Z,13E,15S,17Z)-9α,15-Dihydroxy-11-oxoprosta-5,13,17-trien-1-oic acid;Prosta-5,13,17-trien-1-oic acid, 9,15-dihydroxy-11-oxo-, (5Z,9α,13E,15S,17Z)-;(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]-3-oxocyclopentyl]hept-5-enoic acid
CBNumber:
CB0131898
Molecular Formula:
C20H30O5
Molecular Weight:
350.45
MDL Number:
MFCD00216049
MOL File:
71902-47-1.mol
Last updated:2023-06-08 09:03:09

9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID Properties

Boiling point 561.2±50.0 °C(Predicted)
Density 1.166±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMF: >100 mg/ml (from PGD2); DMSO: >50 mg/ml (from PGD2); Ethanol: >75 mg/ml (from PGD2); PBS pH 7.2: >5 mg/ml (from PGD2)
pka 4.76±0.10(Predicted)
FDA UNII 895XE61E0I

SAFETY

Risk and Safety Statements

9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID price More Price(4)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 12990 Prostaglandin D3 ≥98% 71902-47-1 25μg $65 2024-03-01 Buy
Cayman Chemical 12990 Prostaglandin D3 ≥98% 71902-47-1 50μg $98 2024-03-01 Buy
Cayman Chemical 12990 Prostaglandin D3 ≥98% 71902-47-1 100μg $169 2024-03-01 Buy
AHH MT-09900 9alpha,15S-Dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oicacid 98% 71902-47-1 0.5g $296 2021-12-16 Buy
Product number Packaging Price Buy
12990 25μg $65 Buy
12990 50μg $98 Buy
12990 100μg $169 Buy
MT-09900 0.5g $296 Buy

9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID Chemical Properties,Uses,Production

Uses

Prostaglandin D3 (PGD3) is produced by the metabolism of EPA via the COX pathway. It is equipotent to PGD2 in decreasing systemic blood pressure in rats and in decreasing intraocular pressure in rabbits. However, it is 3-5 times more potent than PGD2 in the inhibition of ADP-induced human platelet aggregation.[Cayman Chemical]

Definition

ChEBI: A member of the class of prostaglandins D that is prosta-5,13,17-trien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,13E,15S,17Z-st reoisomer).

9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID Preparation Products And Raw materials

Raw materials

Preparation Products

9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID Suppliers

Global( 9)Suppliers
Supplier Tel Email Country ProdList Advantage
Shanghai Hongye Biotechnology Co. Ltd 400-9205774 sales@glpbio.cn China 6870 58
Hangzhou Synstar pharmaceutical Technology CO.,Ltd 0571-85361029 synstar518@163.com China 1991 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767 sales@chemegen.com China 11289 58
amyjetsci 027-59626688 18771149750 sales@amyjet.com China 3004 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 8740 58

71902-47-1(9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID)Related Search:

9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID PROSTAGLANDIN D3 (Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]-3-oxocyclopentyl]hept-5-enoic acid (5Z,13E,15S,17Z)-9α,15-Dihydroxy-11-oxoprosta-5,13,17-trien-1-oic acid PGD3 Prostaglandin D3 Prostaglandin D3 Exclusive ANOICLBSJIMQTA-WXGBOJPQSA-N 9α,15S-dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oic acid Prosta-5,13,17-trien-1-oic acid, 9,15-dihydroxy-11-oxo-, (5Z,9α,13E,15S,17Z)- 71902-47-1